FDA lifts hold on AbbVie multiple myeloma study

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 25, 2019 at 7:32 PM.

  1. #1 cafead, Jun 25, 2019 at 7:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,269
    Likes Received:
    3
    via The Food and Drug Administration has lifted a clinical hold on one multiple myeloma trial for AbbVie's Venclexta after making several changes to the study protocols, the big biotech said Monday.

    article source
     
    Quote

Reply to Thread